Showing 201–225 of 278
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue $2.09bn (+6.0%); adjusted operating margin 29.5%.
Net sales rounded in release; diluted EPS $1.94. Full GAAP figures in annual report.
FY2025 revenue $2.73bn (-1.9%); operating margin -33.7%; net loss $1.13bn.
Cash $169.8m; debt $2.65bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Parent Danaher (DHR) group FY2025 revenue $24.57bn (+3.0%); operating margin 19.1%; net income $3.60bn.
Figures cover the whole listed group, not this business alone.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Recent change of ownership; current owner not yet confirmed from official filings.
Financial health not assessed until ownership and accounts are verified.
FY2025 revenue SEK 1.34bn (+12.8%); operating margin 21.7%; net income SEK 228.0m.
Balance sheet figures not captured from release.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2026 revenue $5.65bn (+9.9%); operating margin 33.4%; net income $1.52bn.
Cash $1.47bn; debt $659.4m.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Parent Roche (ROG.SW) group FY2025 revenue CHF 61.52bn (+2.0%); core operating margin 35.5%; net income CHF 13.80bn.
Diagnostics division sales CHF 13.85bn (+2% at constant exchange rates).
FY2026 revenue $41.52bn (+10.0%); operating margin 20.1%; net income $7.46bn.
Cash $7.33bn; debt $14.44bn.
Parent Samsung Electronics (005930.KS) group FY2025 revenue ₩333.60tn; operating margin 13.1%.
Group figures; net profit not stated in release.
FY2025 revenue €36.80bn (+8.0%); operating margin 26.7%; net income €7.49bn.
Net liquidity (net cash) €3.38bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025/26 revenue SEK 3.54bn (+9.3%); operating margin 20.1%; net income SEK 563.8m.
Prior year included a SEK 110m one-off patent settlement.
FY2025 revenue ¥560.7bn; operating margin 13.1%; net income ¥60.5bn.
Balance sheet figures not captured from release.
FY2026 revenue €23.60bn; adjusted EBIT margin 16.2%.
Comparable revenue growth 4.0%; adjusted EBIT about €3.8bn. Net income not captured.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue $6.16bn (+6.1%); operating margin 12.9%; net income $625.0m.
Net debt $2.76bn including leases.
FY2025 revenue $8.32bn (+0.9%); operating margin 26.2%; net income $1.56bn.
Cash $878.0m; debt $5.04bn.